{
DNK

Country

}
UBS Maintains Neutral Rating for Novo Nordisk with Target Price of 1100 Kroner
UBS has maintained a "Neutral" rating for Novo Nordisk, setting a target price of 1100 Danish kroner. Analyst Jo Walton noted a slight increase in first-time prescriptions for weight-loss drugs in the US, based on data up to December 6.
boerse.de
United States Dollar Danish Krone Novo Nordisk A/S DNK Jo Walton
Healthcare, Market Report
15:24 16.12.2024
Novo Nordisk Focuses on Diabetes and Obesity with Global Sales Strategy
Novo Nordisk A/S focuses on the design, manufacture, and marketing of pharmaceutical products, with 92.6% of sales from diabetes and obesity treatments and 7.4% from rare disease therapies, including hemophilia and hormonal disorders. Geographically, sales are distributed as follows: 54.9% in the United States, 21.9% in Europe-Middle East-Africa, 7.2% in China, 3.9% in North America, and 12.1% in other regions.
zonebourse.com
United States Dollar Novo Nordisk A/S DNK USA CHN Show more
Healthcare, Market Report
15:11 16.12.2024
global bisoprolol fumarate market poised for significant growth through 2032
The Global Bisoprolol Fumarate market is projected to grow from USD 1.3 billion in 2023 to USD 2.0 billion by 2032, with a CAGR of 7%. This medication, primarily used for hypertension and heart-related conditions, is expected to see increased demand driven by regulatory changes and market dynamics across various regions, particularly in Europe and Asia-Pacific. Key players include Merck, Pfizer, and Novartis, with a focus on understanding market trends and competitive strategies.
openPR.com
United States Dollar Merck & Co., Inc. Amgen Inc. Alkem Laboratories Limited Mylan Pharmaceuticals Inc. Aurobindo Pharma Limited Teva Pharmaceutical Industries Ltd Dr. Reddy's Laboratories Limited Glenmark Pharmaceuticals Limited CIPLA LTD Sandoz Group AG Pfizer Inc. Bayer AG Hikma Pharmaceuticals PLC AstraZeneca PLC Novartis AG Torrent Pharmaceuticals Limited Sanofi IND ROU BEL HUN DNK POL IDN SGP ARE BRA ZAF FRA THA MEX CZE GBR CHL AUT SAU SWE NOR NLD USA ARG MYS SVK CAN NZL LKA JPN DEU RUS KOR CHN VNM Nidhi Bhavsar Show more
Regulatory & Legal, Market Report
13:09 16.12.2024
UBS Adjusts Carlsberg Target Price Amidst Global Beer Market Dynamics
UBS has reduced its target price for Carlsberg A/S to DKK 800 from DKK 870 while maintaining a neutral stance. The company is a major global beer producer, with 101 million hectoliters sold in 2023, primarily under the Carlsberg and Tuborg brands, and operates 71 breweries across various regions. Its net sales are predominantly from Western Europe (50.7%), followed by Asia (31.7%) and Eastern/Central Europe (17.6%).
MarketScreener
Danish Krone Carlsberg A/S GBR DNK DEU POL CHN Show more
TradFi, Market Report
10:04 12.12.2024
UBS Lowers Carlsberg Target Price to DKK 800 Maintaining Neutral Position
UBS has reduced its target price for Carlsberg to DKK 800 from DKK 870 while maintaining a neutral stance on the company. Carlsberg A/S, a leading global beer producer, sold 101 million hectoliters of beer in 2023, primarily under the Carlsberg and Tuborg brands, and 24.1 million hectoliters of non-alcoholic beverages. The company's sales are distributed across Western Europe (50.7%), Asia (31.7%), and Eastern and Central Europe (17.6%).
Zonebourse
Danish Krone Carlsberg A/S DNK Show more
TradFi, Market Report
10:04 12.12.2024
ubs lowers carlsberg target price amid strong global beer sales
UBS has reduced its target price for Carlsberg A/S to DKK 800 from DKK 870, maintaining a neutral stance on the company. Carlsberg, a leading global beer producer, sold 101 million hectoliters of beer in 2023, primarily under the Carlsberg and Tuborg brands, and also produced 24.1 million hectoliters of non-alcoholic beverages in 2022. The company operates 71 breweries across various regions, with net sales distributed as follows: Western Europe (50.7%), Asia (31.7%), and Eastern/Central Europe (17.6%).
MarketScreener
Danish Krone Carlsberg A/S GBR POL DEU CHN DNK Show more
Finance & Economy, Market Report
10:04 12.12.2024
Coloplast Faces Stock Decline Amid Strategic Shift and Market Challenges
Coloplast A/S has faced a decline in its share price, recently falling to EUR 112.38, reflecting a 4.66% loss over the month. The company, which specializes in medical products for urology and wound care, announced the sale of its skin care division to refocus on core competencies. Despite recent challenges, the share has shown an annual increase of 8.10%.
aktiencheck.de
United States Dollar Euro Coloplast A/S DNK
TradFi, Market Report
01:12 12.12.2024
ubs upgrades coloplast to neutral amid improved market dynamics and growth prospects
UBS has upgraded Coloplast A/S to a "neutral" rating from "sell," citing improved market dynamics and a reassessment of risks. The firm noted reduced competitive pressures and a more conservative market outlook, with expectations of steady growth, projecting an 8% annual revenue increase and an 11% rise in earnings per share from 2024 to 2028. The stock is now trading at a 40% sector premium, aligning with historical averages, and UBS set a price target of DKK 858, reflecting a valuation of 33 times estimated 2025 earnings.
Investing.com
Danish Krone Coloplast A/S DNK
Finance & Economy, Market Report
15:00 11.12.2024
UBS Upgrades Coloplast to Neutral Amid Improved Market Dynamics and Growth Prospects
UBS has upgraded Coloplast A/S to a "neutral" rating from "sell," citing improved market dynamics and reduced risks associated with the company's operations. The revision reflects a reassessment of competitive pressures and growth investments, particularly in wound biologics and continence care. Analysts project an 8% compound annual revenue growth rate and an 11% increase in earnings per share from 2024 to 2028, with the stock trading at a 40% sector premium.
Investing.com
United States Dollar Danish Krone Coloplast A/S DNK
TradFi, Market Report
15:00 11.12.2024
TUI AG Maintains Neutral Rating Amid Diverse Global Tourism Operations
TUI AG, a Germany-based global tourism group, operates through three main segments: Hotels & Resorts, Cruises, and TUI Musement, across Northern, Central, and Western regions. The Hotels & Resorts segment includes group-owned hotel brands, while the Cruises segment features TUI Cruises and Marella Cruises. TUI Musement provides local services at holiday destinations, with regional operations covering the UK, Ireland, Germany, Austria, Poland, Switzerland, Belgium, the Netherlands, and France.
MarketScreener
TUI AG DEU AUT NLD BEL FRA DNK POL CHE GBR IRL Show more
TradFi, Market Report
12:30 11.12.2024
Trending
Subcategory:
Cryptocurrency Markets Stock Market Updates Cryptocurrency Trends Market Sentiment Analysis Central Bank Actions Banking Regulations Corporate Responsibility & ESG Decentralized Finance (DeFi) Innovations Tokenomics and Crypto Economics Mergers & Acquisitions Cryptocurrency & Blockchain Regulations Cryptocurrency Developments Blockchain Technology Adoption Anti-Money Laundering (AML) Regulations Market Analysis and Predictions Emerging Startups Cryptocurrency Regulations Inflation Rates & CPI Data SEC & Financial Compliance Banking & Investment Regulations
Countries:
USA CHE GBR DEU ARE HKG AUS JPN CHN IND SGP DNK CAN NGA FIN COL AUT VGB LIE TUR
Companies:
Credit Suisse Real Estate Fund Siat BlackRock, Inc. Coinbase Global, Inc. Solana USD Ethereum USD Ripples USD Apple Inc. Tesla, Inc. Fidelity Contrafund Cardano USD NVIDIA Corporation Grayscale Litecoin Trust Chainlink USD Tether USDt CNY Google Inc. Amazon.com, Inc. MicroStrategy Inc Franklin Templeton - Franklin M End Federal Reserve USD MicroStrategy Incorporated
Currencies:
United States Dollar Euro Swiss Franc Japanese Yen Australian Dollar Indian Rupee Canadian Dollar Mozambican Metical British Pound Sterling Norwegian Krone Mongolian Tögrög Colombian Peso Singapore Dollar
People:
Donald Trump Ali Martinez Elon Musk Karin Keller-Sutter Jerome Powell Ueli Maurer Michael J. Saylor Thomas Jordan Gary Gensler Colm Kelleher Alan Santana Paul Atkins Joe Rogan Martin Schlegel Isabelle Chassot Mario Nawfal Paolo Ardoino Sergio Ermotti Dana White Joe Biden

MachinaCore is a highly modular and scalable system that allows users to build custom widgets and tools tailored to their specific financial data needs, while seamlessly integrating with other MachinaLabs products, like Machinary, MachinaAI Modules and MachinaTrader.

Links

Address

Waitlist

We’re granting exclusive early access to the first 500 users from december 20.

© 2024 by Machinary.com - Version: 1.0.0.0. All rights reserved

Layout

Color mode

Theme mode

Layout settings

Save settings
Seems like the connection with the server has been lost. It can be due to poor or broken network. Please hang on while we're trying to reconnect...
Oh snap! Failed to reconnect with the server. This is typically caused by a longer network outage, or if the server has been taken down. You can try to reconnect, but if that does not work, you need to reload the page.
Oh man! The server rejected the attempt to reconnect. The only option now is to reload the page, but be prepared that it won't work, since this is typically caused by a failure on the server.